Quibron

Quibron

a trademark for a fixed-combination respiratory drug containing a smooth muscle relaxant (theophylline) and an expectorant (guaifenesin).

Quibron®

A proprietary OTC formulation of guaifenesin and theophylline Indications Expectorant, bronchodilator for common cold, allergies, hay fever, URIs
References in periodicals archive ?
The Quibron family, consisting of four separate dosage forms is indicated for relief and/or prevention of symptoms of asthma and reversible bronchospasm associated with chronic bronchitis and emphysema.
While we are excited about the future of our pipeline products, we are also pleased that Nucofed and Quibron will continue to be offered to the marketplace by Monarch Pharmaceuticals.
Quibron is an important bronchodilator drug which is used for prophylaxis of asthma, a debilitating respiratory disease characterized by narrowed air passages and shortness of breath.
Our sales force will be able to effectively call upon asthma specialists to promote Quibron in anticipation of the expected launch in 1995 of our new anti-asthma drug, Maxivent(R).